diagnostic cancer pancreas :: Article Creator Unlocking Insights Into Pancreatic Cancer And Cachexia In an interview with Targeted Oncology, Sanjay Goel, MD, MS, discussed the mystery of cachexia in pancreatic cancer and why it remains a challenging symptom to target. As 1 of the most lethal cancers, pancreatic cancer remains a disease warranting research and clinical studies. While the lack of targetable mutations and tumor microenvironment make treating pancreatic cancer difficult, 1 of the most challenging symptoms is unrelated to the tumor: cachexia, or more colloquially, wasting syndrome. Cachexia leads to significant muscle mass loss and contributes to poor outcomes in pancreatic cancer treatment. "It's characterized by significant losses in muscle mass, and it's not purely a nutritional deficiency. There are people who believe that overall cachexia is responsible for the deaths of maybe even up to half of all the patien...
Comments
Post a Comment